These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 26635117)
1. Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells. Zhu Y; He W; Gao X; Li B; Mei C; Xu R; Chen H Sci Rep; 2015 Dec; 5():17730. PubMed ID: 26635117 [TBL] [Abstract][Full Text] [Related]
2. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells. Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647 [TBL] [Abstract][Full Text] [Related]
3. EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells. Sugita S; Ito K; Yamashiro Y; Moriya S; Che XF; Yokoyama T; Hiramoto M; Miyazawa K Biochem Biophys Res Commun; 2015 May; 461(1):28-34. PubMed ID: 25858318 [TBL] [Abstract][Full Text] [Related]
4. Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells. Tang MC; Wu MY; Hwang MH; Chang YT; Huang HJ; Lin AM; Yang JC PLoS One; 2015; 10(3):e0119135. PubMed ID: 25807554 [TBL] [Abstract][Full Text] [Related]
5. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326 [TBL] [Abstract][Full Text] [Related]
6. The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells. Mohiuddin M; Kasahara K Cancer Genomics Proteomics; 2021; 18(5):661-673. PubMed ID: 34479918 [TBL] [Abstract][Full Text] [Related]
7. Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Wu M; Yuan Y; Pan YY; Zhang Y Mol Med Rep; 2014 Aug; 10(2):931-8. PubMed ID: 24840891 [TBL] [Abstract][Full Text] [Related]
8. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells. Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130 [TBL] [Abstract][Full Text] [Related]
9. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Chang TH; Tsai MF; Su KY; Wu SG; Huang CP; Yu SL; Yu YL; Lan CC; Yang CH; Lin SB; Wu CP; Shih JY; Yang PC Am J Respir Crit Care Med; 2011 Apr; 183(8):1071-9. PubMed ID: 21037017 [TBL] [Abstract][Full Text] [Related]
10. Heptadecanoic acid inhibits cell proliferation in PC‑9 non‑small‑cell lung cancer cells with acquired gefitinib resistance. Xu C; Wu P; Gao J; Zhang L; Ma T; Ma B; Yang S; Shao G; Yu Y; Huang X; Yang X; Zhang B Oncol Rep; 2019 Jun; 41(6):3499-3507. PubMed ID: 31002344 [TBL] [Abstract][Full Text] [Related]
11. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. Li LH; Wu P; Lee JY; Li PR; Hsieh WY; Ho CC; Ho CL; Chen WJ; Wang CC; Yen MY; Yang SM; Chen HW PLoS One; 2014; 9(8):e104203. PubMed ID: 25105411 [TBL] [Abstract][Full Text] [Related]
12. Inducible EGFR T790M-mediated gefitinib resistance in non-small cell lung cancer cells does not modulate sensitivity to PI103 provoked autophagy. Moreira-Leite FF; Harrison LR; Mironov A; Roberts RA; Dive C J Thorac Oncol; 2010 Jun; 5(6):765-77. PubMed ID: 20421816 [TBL] [Abstract][Full Text] [Related]
13. Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC. Terai H; Soejima K; Yasuda H; Nakayama S; Hamamoto J; Arai D; Ishioka K; Ohgino K; Ikemura S; Sato T; Yoda S; Satomi R; Naoki K; Betsuyaku T Mol Cancer Res; 2013 Jul; 11(7):759-67. PubMed ID: 23536707 [TBL] [Abstract][Full Text] [Related]
14. Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells. Han SY; Zhao MB; Zhuang GB; Li PP Lung Cancer; 2012 Jan; 75(1):30-7. PubMed ID: 21757251 [TBL] [Abstract][Full Text] [Related]
15. EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC. Meng J; Chang C; Chen Y; Bi F; Ji C; Liu W Onco Targets Ther; 2019; 12():6033-6043. PubMed ID: 31440060 [TBL] [Abstract][Full Text] [Related]
16. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways. Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429 [TBL] [Abstract][Full Text] [Related]
17. Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines. Galetti M; Petronini PG; Fumarola C; Cretella D; La Monica S; Bonelli M; Cavazzoni A; Saccani F; Caffarra C; Andreoli R; Mutti A; Tiseo M; Ardizzoni A; Alfieri RR PLoS One; 2015; 10(11):e0141795. PubMed ID: 26536031 [TBL] [Abstract][Full Text] [Related]
18. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers. Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344 [TBL] [Abstract][Full Text] [Related]
19. Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines. Nishimura Y; Takiguchi S; Yoshioka K; Nakabeppu Y; Itoh K Int J Oncol; 2012 Oct; 41(4):1520-30. PubMed ID: 22859339 [TBL] [Abstract][Full Text] [Related]
20. Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. Mukai S; Moriya S; Hiramoto M; Kazama H; Kokuba H; Che XF; Yokoyama T; Sakamoto S; Sugawara A; Sunazuka T; Ōmura S; Handa H; Itoi T; Miyazawa K Int J Oncol; 2016 Jan; 48(1):45-54. PubMed ID: 26718641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]